Allogeneic Cell Therapy market 2023 – Industry Growth by 2035

Allogeneic Cell Therapy market 2023 – Industry Growth by 2035

Considering the potential benefits of allogeneic cell therapies, several researchers and industry stakeholders have been continuously exploring such therapy candidates for applications across a myriad of disease indications


Roots Analysis is pleased to announce the publication of its recent study, titled, “Allogeneic Cell Therapy Market, 2023-2035.”


The research report presents an in-depth analysis, highlighting the capabilities of various stakeholders in this market, across different geographies. Amongst other elements, the market report includes:


  • A detailed assessment of the overall landscape of allogeneic cell therapies and allogeneic therapy developers based on several relevant parameters.
  • A detailed analysis of the partnerships established between stakeholders engaged in this industry, since 2019
  • An analysis of the funding and investments that have been made into companies developing allogeneic cell therapies
  • An analysis of completed and ongoing clinical trials related to allogeneic cell therapies, based on several relevant parameters
  • An insightful analysis, highlighting the key opinion leaders (KOLs) investigating clinical trials related to allogeneic cell therapies.
  • A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)


  • Type of Cell Therapy
  • Stem Cell
  • Virus-Specific T-Cell
  • Regulatory T-Cell


  • Source of Cell
  • Bone Marrow / Matrix
  • Adipose Tissue
  • Peripheral Blood
  • Umbilical Cord
  • Placenta
  • Others


  • Target Indication
  • Infectious Diseases
  • Chronic Heart Failure
  • Crohn’s Disease
  • Ischemic Stroke
  • Hematological Cancer
  • Bone Diseases
  • Critical Limb Ischemia
  • Graft versus Host Disease
  • Duchenne Muscular Dystrophy
  • Epidermolysis Bullosa
  • Diabetic Foot Ulcer
  • Others


  • Therapeutic Area
  • Post-Transplant Infections
  • Cardiovascular Disorders
  • Autoimmune / Inflammatory Disorders
  • Cerebrovascular Disorders
  • Oncological Disorders
  • Musculoskeletal Disorders
  • Neurological Disorders
  • Genetic Disorders
  • Others


  • Key Geographical Regions
  • North America
  • Europe
  • Asia-Pacific and Rest of the World


Key companies (based on the number of allogeneic cell therapies being developed; arranged in alphabetical order) covered in the report

  • Artiva Biotherapeutics
  • Allogene Therapeutics
  • Celularity
  • Cellenkos
  • Cell2Cure
  • CHABiotech
  • CRISPR Therapeutics
  • Fate Therapeutics
  • Fundamenta Therapeutics
  • GC Cell
  • Mesoblast
  • Nanjing Bioheng Biotech
  • Stemedica Cell Technologies


To view more details on this report, click on the link


News article

Blockchain in Drug Discovery and Clinical Trials Market


Learn from experts:  do you know about these emerging industry trends?

Top 10 Companies Offering Oral Solid Dosage Manufacturing Services

Top 10 Quantum Computing Companies Transforming Drug Discovery


About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.


Learn more about Roots Analysis consulting services:

Connect with our Roots Analysis Consulting team: For your custom research exclusive best-in-class quality projects



Ben Johnson

+1 (415) 800 3415




Tags: , , , ,

Like what you've read?

Join thousands of other traders who receive our newsletter containing; market updates, tutorials, learning articles, strategies and more.

Previous Entry   Next Entry